thorhildur
- 29 Jan 2006 11:45
Two new broker notes out last week on this one -
Collins Stewart gives a target valuation for the combined entity of 26 million or 156p per share
Edison Investments embedded valuation is 31m - Indicating a 100% gain in share price from current levels. They suggest that using the current embedded valuation model, the current value of Angles six non-exited ventures is only 5.5m - suggesting Angle to be SIGNIFICANTLY UNDERVALUED
Have a look
dreamcatcher
- 29 Sep 2011 11:44
- 88 of 195
Good call gibby
machoman
- 29 Sep 2011 11:56
- 89 of 195
re - dreamcatcher - 29 Sep 2011 11:44 - 88 of 88
Good call gibby
I wonder if you follow the stock, sell at 56p and missed of the way to 79p
machoman
- 29 Sep 2011 12:03
- 90 of 195
re - gibby - 28 Sep 2011 21:02 - 82 of 88
hi macho ref 77 / 81 - you will note i only said consider selling to buy back later, which means keep an eye on level 2 - be sensible as opposed to greedy and if happy cash in - i did not say sell but only consider
that is not what you said, just read it again and stop to cover you bad sugestion.
Any stock with a large rise and large volume will have another day of rise if is two before profit taking is recomended. On small stocks is very difficult to sell and buy back on the same day as MMs use tricks and large spreads, many try it yesterday and had to pay higher price.
gibby - 28 Sep 2011 12:51 - 75 of 91
re - those in before today's hike should consider selling and buying back later!!! :-))))
dreamcatcher
- 29 Sep 2011 12:04
- 91 of 195
Machoman its a very good stock. Wish I did have it. gl
gibby
- 29 Sep 2011 13:32
- 92 of 195
lol macho - i said consider sell to buy back not sell read it again - you twisted my words a tad there :-))
however today's low was 51p - high 70 odd pence - i think that speaks for itself - btw
you wont have any problem buying if quick enough
this for me now is one for the future more 2013 before seeing real increases to 3 figures here
pharma is not a cheap industry more funds will be needed and notoriously slow
momentum from p.i.s is all thats left for now here until further news imo
anyhow people could have top sliced remember
gibby
- 29 Sep 2011 13:33
- 93 of 195
hi dc - seen similar to agl many time - even in recent times such as pym / phytopharm, pyc, sar etc - it will happen again
nothing wrong with agl but needs a reality check
hope you are having a good day
machoman
- 29 Sep 2011 14:55
- 94 of 195
gibby
There is no LOL but BAD recomendation from you, you can twisted and turn it 1 million
times. ( if you do not sell how are you going to buy back )
The proof is on the pudding
at the time of saying it was 56p and went this morning to 79p.
re - however today's low was 51p
Your nonsence goes further as you do not know lows and highs of the day also
Missed this morning 23p ( 79 - 56p ) I gain 23p
retracement to 52p this morning you gain 4p ( if you say is time to buy back low of the day)
Just tell me who is right?
skinny
- 29 Sep 2011 15:07
- 95 of 195
Here we go again :-)
gibby
- 29 Sep 2011 15:43
- 96 of 195
well i did say consider - no more
i didnt say - this is a strong sell get out now and buy later - i said consider it is that simple
gibby
- 29 Sep 2011 15:43
- 97 of 195
and i still say it as you may also want to consider buying now to sell later - lol!! then again you might not
machoman
- 29 Sep 2011 15:51
- 98 of 195
I hope someone is not ......... Full as a tick
or maybe ....................Fur coat and no knickers
after all maybe ............The game/the cake is not worth the candle
some need .............. Get one's act together
allways trying to ........ Get a second bite/ two bites at the cherry
too many .....................Shilly-shally
it allways could be ...............Silver lining
gibby
- 29 Sep 2011 20:57
- 99 of 195
macho i hope you made some money here but personally would not want to be hanging around here - this is as i repeat one for the future and next good news rns - iis will purchase once the sp has dropped again - should hit sub 40 in the coming months with ease - no disrespect to the company just the way it is - todays volume was relatively low compared to yesterdays highs - best not to look at the sp - volumes far more important - that is a fact and gl
machoman
- 30 Sep 2011 08:35
- 100 of 195
The marked down at the start, has encourage buyers and is bouncing back fast
54.50p was the lowest price paid on the bounce back.
Moneyam trades gives 81k buys for 48K sells, and yet is down so far.
machoman
- 30 Sep 2011 10:12
- 101 of 195
The buyers are having a good fun to the MMs games and the last one was a large one 25K @ 62p ( 5 times NMS )

moneyam, as usual nothing goes right so chart from others
machoman
- 30 Sep 2011 11:34
- 102 of 195
64.75p +5p
Merchant Securities Initiation Note on ANGLE - 119p price target
Parsortix delivery on capturing CTCs
ANGLE has been making substantial progress since its last fundraising
and, in our view, is poised to deliver on a number of fronts.
Recent demand for the Geomerics Enlighten platform is picking
up, with an exciting picture building in Parsortix, in particular. We
look forward to news flow in the coming months and initiate
coverage on the stock with a BUY rating and 119p price target.
The validation work successfully conducted by Parsortix has demonstrated that
the device it is developing can be used (reproducibly) to isolate and capture small
numbers of cancer cells from whole blood. The device has apparently captured all
of the cancer cells present in blood used in the experiments. We believe that this
achievement and milestone will enable the characterisation of cancer cells within
the device, without the need to extract them or use of the complex assay based
approach of the main competitor technology.
This potential breakthrough could open up a large market opportunity for Parsortix
with opportunities for early revenues through the launch of a research use device.
# We believe that the Parsortix technology has strong value as an applied research
tool, which could be followed by a number of different clinical applications.
#The risks to our investment thesis relate to the failure of one or more technologies
in the various venture businesses and a decline in the revenues derived from the
management-consulting business.
# We initiate coverage of ANGLE with a BUY rating and a target price of 119p,
driven by a sum-of-the-parts valuation of the constituent components of the
business.
gibby
- 30 Sep 2011 12:14
- 103 of 195
had a quick day trade myself here earlier today - easy cash - hope others did also - but i do not intend hanging around despite broker note - this afternoon will be very telling after around 3pm - gla - good luck if anyone stays the course beyond today
mitzy
- 30 Sep 2011 12:58
- 104 of 195
Incredible share(not a holder) but will watch.
gibby
- 30 Sep 2011 13:00
- 105 of 195
lol in for another day trade i must be bonkers - seeking 80p! yeeeehaaaaa!!! then out 75p will do!!!
gibby
- 30 Sep 2011 13:31
- 106 of 195
interesting
Resistance 2 103.2
Resistance 1 70.67
relatively low volume shares in circulation
HARRYCAT
- 30 Sep 2011 13:32
- 107 of 195
I'm same as you mitzy. Just watching from the sidelines, but seems to be trading momentum causing the bounces now and dangerous territory, imo.